Literature DB >> 11388206

Short-term hemodynamic performance of the mitral Carpentier-Edwards PERIMOUNT pericardial valve. Carpentier-Edwards PERIMOUNT Investigators.

M S Firstenberg1, A J Morehead, J D Thomas, N G Smedira, D M Cosgrove, M A Marchand.   

Abstract

BACKGROUND: Although long-term durability data exist, little data are available concerning the hemodynamic performance of the Carpentier-Edwards PERIMOUNT pericardial valve in the mitral position.
METHODS: Sixty-nine patients who were implanted with mitral PERIMOUNT valves at seven international centers between January 1996 and February 1997 consented to participate in a short-term echocardiography follow-up. Echocardiographs were collected at a mean of 600+/-133 days after implantation (range, 110 to 889 days); all underwent blinded core lab analysis.
RESULTS: At follow-up, peak gradients were 9.09+/-3.43 mm Hg (mean, 4.36+/-1.79 mm Hg) and varied inversely with valve size (p < 0.05). The effective orifice areas were 2.5+/-0.6 cm2 and tended to increase with valve size (p = 0.08). Trace mitral regurgitation (MR) was common (n = 48), 9 patients had mild MR, 1 had moderate MR, none had severe MR. All MR was central (n = 55) or indeterminate (n = 3). No paravalvular leaks were observed. Mitral regurgitation flow areas were 3.4+/-2.8 cm2 and were without significant volumes.
CONCLUSIONS: In this multicenter study, these mitral valves are associated with trace, although physiologically insignificant, central MR. Despite known echocardiographic limitations, the PERIMOUNT mitral valves exhibit similar hemodynamics to other prosthetic valves.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Year:  2001        PMID: 11388206     DOI: 10.1016/s0003-4975(01)02514-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Effects of Transapical Transcatheter Mitral Valve Implantation.

Authors:  Ming-Chon Hsiung; Wei-Hsian Yin; Yung-Tsai Lee; Tien-Ping Tsao; Kuo-Chen Lee; Kuan-Chih Huang; Pei-En Chen; Wei-Hsuan Chiang; Tao-Hsin Tung; Jeng Wei
Journal:  Front Cardiovasc Med       Date:  2021-06-11

2.  The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability.

Authors:  Gabriel Loor; Andres Schuster; Vincent Cruz; Aldo Rafael; William J Stewart; James Diaz; Kenneth McCurry
Journal:  J Cardiothorac Surg       Date:  2016-01-27       Impact factor: 1.637

3.  Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial.

Authors:  C S Hiremath; Anil R Jain; Anurag Garg; Nirmal Gupta; Yugal K Mishra; Zile Singh Meharwal; Nityanand Thakur; Atul A Maslekar; Naman Shastri
Journal:  J Cardiothorac Surg       Date:  2020-06-15       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.